Cargando…

Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a common subtype of interstitial lung disease (ILD). Information about the associated comorbidities and predictors of survival among Saudi patients with IPF is limited. AIMS: The aim of the study was to determine the clinical characteristics, associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhamad, Esam H., Cal, Joseph G., Alrajhi, Nuha N., Aharbi, Waleed M., AlRikabi, Ammar C., AlBoukai, Ahmad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720745/ https://www.ncbi.nlm.nih.gov/pubmed/33381235 http://dx.doi.org/10.4103/atm.ATM_230_20

Ejemplares similares

Clinical characteristics and outcomes in patients with primary Sjogren's syndrome-associated interstitial lung disease
por: Alhamad, Esam H., et al.
Publicado: (2021)

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: Unusual presentation
por: Alrajhi, Nuha Nasser, et al.
Publicado: (2019)

Acute exacerbation in interstitial lung disease
por: Alhamad, Esam H., et al.
Publicado: (2021)

Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis
por: Alhamad, Esam H, et al.
Publicado: (2013)

Pulmonary hypertension in Saudi Arabia: A single center experience
por: Alhamad, Esam H., et al.
Publicado: (2013)

Predictors of Mortality in Patients with Interstitial Lung Disease-Associated Pulmonary Hypertension
por: Alhamad, Esam H., et al.
Publicado: (2020)

Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients
por: Alhamad, Esam H., et al.
Publicado: (2010)

Pirfenidone treatment in idiopathic pulmonary fibrosis: A Saudi experience
por: Alhamad, Esam H.
Publicado: (2015)

Plasmablastic lymphoma of the rectum: case report of a rare location and literature review
por: AlMohamedi, Razan Saleh, et al.
Publicado: (2022)

Rapid detection of circulating fibrocytes by flowcytometry in idiopathic pulmonary fibrosis
por: Alhamad, Esam H., et al.
Publicado: (2015)

Predictors of mortality in interstitial lung disease patients without pulmonary hypertension
por: Alhamad, Esam H., et al.
Publicado: (2020)

A study of chronic obstructive pulmonary disease-specific causes of osteoporosis with emphasis on the emphysema phenotype
por: Fouda, Mona Ali, et al.
Publicado: (2017)

Post-COVID-19 pulmonary fibrosis: An ongoing concern
por: Alrajhi, Nuha Nasser
Publicado: (2023)

Endobronchial biopsy in the final diagnosis of chronic obstructive pulmonary disease and asthma: a clinicopathological study
por: Arafah, Maria Abdulrahim, et al.
Publicado: (2018)

Managing comorbidities in idiopathic pulmonary fibrosis
por: Fulton, Blair G, et al.
Publicado: (2015)

Comorbidities and Complications in Idiopathic Pulmonary Fibrosis
por: Cano-Jiménez, Esteban, et al.
Publicado: (2018)

Linear dermatomyofibroma over the nape of neck: a report of an unusual case and literature review
por: AlZamil, Lama R, et al.
Publicado: (2019)

Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue
por: Caminati, Antonella, et al.
Publicado: (2019)

LBODP017 Unusual Presentation Of Brown Tumors In Tertiary Hyperparathyroidism: A Case-based Review
por: ALShehri, Sara Mohammed, et al.
Publicado: (2022)

Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
por: Kreuter, Michael, et al.
Publicado: (2016)

Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
por: Kärkkäinen, Miia, et al.
Publicado: (2017)

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
por: Oldham, Justin M., et al.
Publicado: (2017)

Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data
por: Khan, Mohammed Ayaz, et al.
Publicado: (2023)

Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis
por: Millan-Billi, Paloma, et al.
Publicado: (2018)

Molecular subtypes of breast carcinoma in Saudi Arabia: A retrospective study
por: Alnegheimish, Norah A., et al.
Publicado: (2016)

Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?
por: Alfaro, Tiago M., et al.
Publicado: (2020)

Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study
por: Lee, Jang Ho, et al.
Publicado: (2023)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Re: Prevalence of chronic obstructive pulmonary disease among smokers attending primary health-care clinics in Saudi Arabia
por: Al-Kassimi, Feisal A., et al.
Publicado: (2011)

Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
por: Fisher, J. H., et al.
Publicado: (2019)

The six-minute walk test in patients with pulmonary sarcoidosis
por: Alhamad, Esam H.
Publicado: (2009)

Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management
por: van Cleemput, Johan, et al.
Publicado: (2018)

Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study
por: Jovanovic, Dragana M., et al.
Publicado: (2022)

Idiopathic Pulmonary Comorbidities and Mechanisms
por: Pacurari, Maricica, et al.
Publicado: (2021)

Clinical characteristics and computed tomography findings in Arab patients diagnosed with pulmonary sarcoidosis
por: Alhamad, Esam H., et al.
Publicado: (2009)

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
por: Glaspole, Ian, et al.
Publicado: (2021)

Idiopathic pulmonary fibrosis patients with severe physiologic impairment: characteristics and outcomes
por: Pastre, Jean, et al.
Publicado: (2021)

Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
por: Yan, Wei, et al.
Publicado: (2015)

Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry
por: Wuyts, Wim A, et al.
Publicado: (2018)

Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib
por: Rahaghi, Franck, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_42ckpp0frt6mqda4tc7k67mggp